These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12800896)

  • 1. Health for all or riches for some: WHO's responsible?
    Motchane JL
    Int J Health Serv; 2003; 33(2):395-400. PubMed ID: 12800896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 3. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 4. Patently necessary: improving global access to essential medicines.
    CMAJ; 2003 Dec; 169(12):1257, 1259. PubMed ID: 14662658
    [No Abstract]   [Full Text] [Related]  

  • 5. Patents and access to essential drugs.
    Loff B
    Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to medicines and global health: will Canada lead or flounder?
    Orbinski J
    CMAJ; 2004 Jan; 170(2):224-6. PubMed ID: 14734437
    [No Abstract]   [Full Text] [Related]  

  • 7. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 8. The performance and problems of the Turkish pharmaceutical industry: is there a need to develop a national drug policy?
    Kisa A
    J Med Syst; 2001 Oct; 25(5):309-18. PubMed ID: 11508904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 10. Essential medicines out of reach for most people.
    Indian J Med Sci; 2008 Dec; 62(12):520-1. PubMed ID: 19402257
    [No Abstract]   [Full Text] [Related]  

  • 11. How do patents and economic policies affect access to essential medicines in developing countries?
    Attaran A
    Health Aff (Millwood); 2004; 23(3):155-66. PubMed ID: 15160813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Conflicts of Interest in WHO's Consultative Processes on Global Alcohol Policy.
    Leung JY; Casswell S
    Int J Health Policy Manag; 2022 Oct; 11(10):2219-2227. PubMed ID: 34814668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 15. [The World Health Organization is 50 years old].
    Rev Panam Salud Publica; 1998 Oct; 4(4):282-6. PubMed ID: 9924509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ensuring new medicines reach those in most need.
    Burrone E; Perry G
    Lancet HIV; 2015 Sep; 2(9):e362-3. PubMed ID: 26423544
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-five years of essential medicines.
    Quick JD; Hogerzeil HV; Velasquez G; Rago L
    Bull World Health Organ; 2002; 80(11):913-4. PubMed ID: 12481216
    [No Abstract]   [Full Text] [Related]  

  • 18. Essential medicines twenty-five years on: closing the access gap.
    Quick JD
    Health Policy Plan; 2003 Mar; 18(1):1-3. PubMed ID: 12582103
    [No Abstract]   [Full Text] [Related]  

  • 19. Compulsory pharmaceutical patent licensing in Brazil: the controversy of public interest.
    Rodrigues da Silva C; Galvão de Botton L
    Pharm Pat Anal; 2013 Nov; 2(6):685-7. PubMed ID: 24237232
    [No Abstract]   [Full Text] [Related]  

  • 20. The global drug gap: policy implications for microbicides.
    Reich MR
    AIDS; 2001 Feb; 15 Suppl 1():S14-7. PubMed ID: 11403006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.